Hasil Pencarian  ::  Simpan CSV :: Kembali

"Demam berdarah dikenal luas sebagai salah satu beban bagi kesehatan global. Sebagai salah satu penyakit yang ditularkan artropoda yang paling umum, jumlah kasusnya meningkat setiap tahun di Indonesia. Jika tidak segera diobati, penyakit ini dapat berkembang menjadi kondisi yang lebih parah. Sayangnya, pengobatan untuk demam berdarah masih belum spesifik. Dalam penelitian ini, xanthone dievaluasi pengaruhnya terhadap replikasi virus dengue secara in vitro pada human cell line Huh7it-1. Efek dari sifat antivirus xanthone dikuantifikasi menggunakan nilai IC50. Penentuan persentase penghambatan dihitung menggunakan perbandingan jumlah uji fokus dan DMSO sebagai kontrolnya. Di sisi lain, viabilitas sel dihitung menggunakan uji MTT dan kemudian dibandingkan dengan nilai viabilitas kontrol DMSO. Dari penelitian ini didapatkan hasil IC50 sebesar 13,707 μg/ml. Hasil CC50 yang didapat sebesar 2,7 μg/ml. Kedua nilai tersebut menghasilkan indeks selektivitas sebesar 0,19. Meskipun xanthone menunjukkan kemampuan untuk menghambat replikasi virus dengue, di sisi lain xanthone juga menunjukkan toksisitas terhadap sel. Xanthone bukan kandidat potensial untuk menjadi antivirus dengue karena indeks selektivitasnya yang rendah. Penelitian lebih lanjut disarankan untuk memodifikasi struktur xanthone untuk mengurangi sitoksisitasnya.

---

Dengue fever is widely known as one of the global health burden. As one of the most common arthropod-borne illness, the number of the cases increases every year in Indonesia. Furthermore, when it is not treated promptly, this disease could progress into a more severe condition. Unfortunately, the treatment for dengue fever is still not specific. In this research, xanthone is evaluated for its effect on dengue virus replication in vitro using the human cell line, Huh7it-1. The effect of the antiviral properties of xanthone is quantified using the IC50 value. The determination of the inhibition percentage is calculated using the comparison of the amount of focus assay and DMSO as its control. On the other hand, cell viability is calculated using the MTT assay and then compared with the value of DMSO control viability. From this experiment, the result of the IC50 of xanthone is 13.707 μg/ml. The CC50 obtained is 2.7. It results in the value of selectivity index, which is 0.19. Even though xanthone shows the ability to inhibit dengue viral replication, in the other hand it also exhibits toxicity towards the cell. Thus, xanthone is not a potential candidate to become dengue antiviral due to its low selectivity index. Further research is suggested to modify xanthone’s structure to reduce its cytoxicity."

"Tingginya insiden infeksi demam berdarah yang terjadi dan tidak adanya vaksin efektif menyebabkan banyak peneliti mencoba ekstrak tumbuhan sebagai pengobatan alternatif pada virus Dengue (DENV). Curcumin merupakan salah satu ekstrak tumbuhan yang telah dibuktikan memiliki efek antiviral. Penelitian ini bertujuan untuk mengetahui apakah curcumin memiliki efek antiviral pada virus dengue. Oleh karena itu dilakukan tes untuk mengetahui persen hambatan curcumin pada replikasi DENV dan efek cytotoxic curcumin pada sel mamalia. Penelitian ini merupakan penelitian eksperimental yang dilakukan di Departemen Mikrobiologi FKUI. Pada penelitian ini terdapat enam kelompok yaitu perlakuan oleh curcumin dengan empat konsentrasi yang berbeda kontrol negatif dan juga Dimethil Sulfoxide (DMSO). Data yang didapatkan dari eksperimen ini akan dianalisis dengan metode T-test. Dari hasil penelitian terlihat bahwa curcumin terbukti dapat menghambat replikasi virus dengue. Pemberian dosis yang lebih tinggi dapat menghambat 100% replikasi virus. Pada saat konsentrasi curcumin diturunkan, maka penghambatan replikasi DENV secara dratis menurun. Dari data tersebut IC50 dari curcumin diperoleh yaitu kurang dari 0.1 µg/ml. Hasil data menunjukkan bahwa efek cytotoxic curcumin pada sel sangat signifikan pada kosentrasi yang tinggi. Pada konsentrasi yang lebih rendah, viabilitas sel terhitung lebih tinggi. Dari data tersebut dapat dihitung nilai CC50 yaitu 3,46 µg/ml. Dengan membandingkan nilai CC50 dan IC50 dari curcumin, didapatkan nilai selectivity index yaitu lebih dari 34. Dari penelitian ini dapat disimpulkan bahwa curcumin dapat digunakan sebagai antiviral virus dengue di masa mendatang.

---

The high incidence of dengue virus infection and also the absence of effective vaccine cause researchers to look up to use the natural extract as the alternative remedy against the dengue virus (DENV). Curcumin is one of the natural extracts that has already proven to have antiviral effect. The objective of this study experiment aimed to see whether curcumin can be used as the antiviral against dengue virus. Several experiments were conducted to obtain the percentage of inhibition of DENV replication and also to determine the cytotoxic effect of curcumin to mammalian cells. This study was an experimental study that had been conducted at Microbiology Departement of Faculty Medicine of Universitas Indonesia. In this experiment, there were six treatment groups such as four different concentrations of curcumin, negative control and Dimethyl sulfoxide (DMSO). The data from this study were analyzed using T-test method. From this study, the curcumin had been proven to successfully inhibit the replication of dengue virus. The treatment with higher dose of curcumin could totally inhibit the replication of DENV. When we gave less dose of curcumin, the percentage inhibition dropped significantly. This showed that inhibition by curcumin was in dose-dependent manner. Furthermore, from these data we determined the IC50 of curcumin which was less than 0.1 µg/ml. The CC50 of curcumin was 3,46µg/ml. By comparing the result of CC50 and IC50, we found the selectivity index value was more than 34. From this study, it can be concluded that Curcumin can be used as antiviral against dengue virus in the future."

"[Demam berdarah dengue adalah penyakit yang dikenal di dunia dan disebabkanoleh infeksi virus dengue (DENV). Meskipun prevalensi penyakit ini cukuptinggi, pengobatan infeksi dengue masih terbatas pada pengobatan suportif.Cyclosporine A telah banyak digunakan sebagai pengobatan infeksi Hepatitis C.Virus hepatitis C dan DENV adalah virus RNA dari genus yang sama, yakniflavivirius. Hingga saat ini, masih belum ada pengobatan untuk infeksi DENV,oleh karena itu kami melakukan penelitian untuk mengetahui efektivitasCyclosporine A. Cyclosporine A digunakan sebagai antiviral infeksi DENV.Dalam penelitian ini kami menggunakan DENV serotipe 1 dan Vero Cell untukpercobaan antivirus in vitro. Kami melakukan pengenceran Cyclosporine Amenggunakan Dymethil sulfoxide (DMSO). Kami memaparkan DENV yangdiinfeksikan kepada sel Vero dengan empat konsentrasi aman dari CyclosporineA, yaitu 5 ug/ml, 1 ug/ml, 0,5 ug/ml, dan 0,1 ug/ml, dan DMSO sebagai kontroldari percobaan kami karena fungsinya yang sebagai materi pelarut dariCyclosporine A. Setelah itu, diinkubasikan selama 3 hari untuk mengetahui efekCyclosporine A terhadap replikasi DENV. Setelah masa inkubasi selesai, kamimemeriksa viabilitas sel Vero dengan menggunakan MTS Assay untukmengetahui efek sitotoksik dari Cyclosporine A. Kami memperoleh hasil IC50 dariFocus Assay dan CC50 dari MTS Assay. Kami juga menentukan indeksselektivitas penelitian yang merupakan perbandingan nilai IC50 dan CC50. Daripenelitian ini, Cyclosporine A telah terbukti memiliki aktivitas antivirus terhadapDENV dengan nilai IC50 sebesar 0,4 ug/ml dan CC50 sebesar 68,47 ug/ml.Sedangkan nilai indeks selektivitas adalah 171. Hal tersebut diatas menunjukanbahwa Cyclosporine A merupakan kandidat antiviral terhadap DENV dimasamendatang., Dengue hemorrhagic fever is world-known disease caused by the infection ofDENV. Despite the high prevalence of this disease, the treatment of dengueinfection is still limited to the supportive treatment. Cyclosporine A has beenwidely used as the treatment of Hepatitis C infection. Hepatitis C virus and DENVare RNA virus from the same genus, flavivirius genus. Up until now, there is stillno absolute treatment for DENV infection, thus we conduct this research to checkthe possibility of Cyclosporine A as the treatment of DENV infection. In thisstudy we used DENV Serotype 1 and Vero Cell for antiviral invitro experiment.We then diluted the Cyclosporine A using Dymethil Sulfoxide (DMSO). Wetreated the cells with four different safe concentrations of Cyclosporine A (5μg/ml, 1 μg/ml, 0.5 μg/ml, and 0.1 μg/ml) and DMSO as the negative control toour study because it functioned as the dilution material of Cyclosporine A. Afterthat, we incubated it for 3 days. Once the incubation period finished, we checkedusing Cell Viability Assay and Focus assay. We obtained the result of IC50 fromthe Focus Assay and we obtained the result of CC50 from Cell Viability Assay.We also determined the selectivity index of the study. From this study,Cyclosporin A has proven to have antiviral activity against DENV. The IC50 is 0.4μg/ml, CC50 is 68.47 μg/ml, and selectivity index is 171.]"

"[ABSTRAKDemam berdarah dengue (DBD) adalah penyakit paling umum di negara-negara tropis dan sub-tropis dan ditransmisikan melalui gigitan nyamuk. Namun hingga saat ini, belum ada pengobatan yang spesifik ataupun vaksin untuk DBD. Penelitian ini bertujuan untuk mengevaluasi pengaruh Ribavirin pada replikasi virus dengue (DENV). Penelitian ini merupakan penelitian eksperimental in Vitro yang dilaksanakan di Laboratorium Departemen Mikrobiologi. Kami menggunakan sel Vero dan DENV serotype 1 koleksi Departemen Mikrobiologi. DENV, yang kemudian dipaparkan dengan berbagai konsentrasi Ribavirin dengan 6 kali pengulangan. Sebagai pembanding, kami menggunakan DENV yang dipaparkan dengan pelarut yaitu dimetil sulfoksida (DMSO), sedangkan DENV yang tidak dipaparkan dengan ribavirin atau pelarut digunakan sebagain control negative. Uji fokus digunakan untuk menentukan persentasi inhibisi dari replikasi DENV. Untuk menentukan efek sitotoksik dari ribavirin, kami menggunakan MTS assay (3-(4,5-dimethylthiazol-2-yl)-5-(3 arboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium). Ribavirin dengan konsentrasi 5μg/mL, menghambat replikasi virus sebesar 75% jika dibandingkan dengan DMSO. Pada konsentrasi 1 μg/mL, 0.5 μg/mL, dan 0.1μg/mL, ribavirin menghambat replikasi virus masing-masing sebesar 64%, 46%, dan 50% dan secara statistk menunjukkan perbedaan bermakna. Dari data yang didapat dalam penelitian ini, half inhibitory concentration (IC50) adalah 0.25 μg/mL. Hasil uji MTS menunjukkan bahwa half cytotoxic concentration (CC50) adalah 106.83 μg/mL sehingga ribavirin termasuk dalam katagori tidak toksik. Dari penelitian ini dapat disimpulkan bahwa, ribavirin memiliki inhibisi yang kuat terhadap replikasi terhadap replikasi DENV dan memiliki sitotoksisitas rendah terhadap sel-sel

---

ABSTRACTDengue hemorrhagic fever (DHF) is the most common disease in tropical and sub-tropical countries and is transmitted by mosquito bite. Hitherto, there is still no specific treatment or vaccine for DHF. This study aimed to evaluate the effect of ribavirin to the replication of dengue virus (DENV). This study was an in vitro experimental study that was conducted in Microbiology Department Laboratory.We used vero cells and DENV serotype 1 from the collection of Microbiology Department. DENV was exposed with different concentrations of ribavirin with 6 times of repetition. As a comparison, we used DENV that was exposed to diluent which is dimethyl sulfoxide (DMSO), while DENV that was no exposed to any ribavirin or diluent was used as control negative. Focus assay was used to determine percentage of inhibition of the DENV replication. To determine cytotoxicity effect of ribavirin, we used MTS assay (3-(4,5 dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4sulfophenyl)-2H-tetrazolium). Ribavirin with the concentration of 5μg/mL inhibited virus replication by 75% compared to DMSO. On concetration 1 μg/mL, 0.5 μg/mL, dan 0.1μg/mL, ribavirin inhibited virus replication by 64%, 46%, dan 50%, respectively and statiscally showed significant difference. From the data obtained in this study, the half inhibitory concentration (IC50) was 0.25 μg/mL. The result from MTS assay showed that half cytotoxic concentration (CC50) was 106.83 μg/mL, therefore ribavirin was categorized as non-toxic. In conclusion, ribavirin has a strong inhibition towards the replication of DENV and has a low cytotoxicity to healthy cells., Dengue hemorrhagic fever (DHF) is the most common disease in tropical and sub-tropical countries and is transmitted by mosquito bite. Hitherto, there is still no specific treatment or vaccine for DHF. This study aimed to evaluate the effect of ribavirin to the replication of dengue virus (DENV). This study was an in vitro experimental study that was conducted in Microbiology Department Laboratory.We used vero cells and DENV serotype 1 from the collection of Microbiology Department. DENV was exposed with different concentrations of ribavirin with 6 times of repetition. As a comparison, we used DENV that was exposed to diluent which is dimethyl sulfoxide (DMSO), while DENV that was no exposed to any ribavirin or diluent was used as control negative. Focus assay was used to determine percentage of inhibition of the DENV replication. To determine cytotoxicity effect of ribavirin, we used MTS assay (3-(4,5 dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4sulfophenyl)-2H-tetrazolium). Ribavirin with the concentration of 5μg/mL inhibited virus replication by 75% compared to DMSO. On concetration 1 μg/mL, 0.5 μg/mL, dan 0.1μg/mL, ribavirin inhibited virus replication by 64%, 46%, dan 50%, respectively and statiscally showed significant difference. From the data obtained in this study, the half inhibitory concentration (IC50) was 0.25 μg/mL. The result from MTS assay showed thathalf cytotoxic concentration (CC50) was 106.83 μg/mL, therefore ribavirin was categorized as non-toxic. In conclusion, ribavirin has a strong inhibition towards the replication of DENV and has a low cytotoxicity to healthy cells.]"

"Virus dengue (DENV) menyebabkan penyakit infeksi akut yang dapat menyebabkan kematian. Infeksi dengue masih menjadi masalah kesehatan terutama di negara-negara tropis akibat morbiditas dan mortalitas yang dapat ditimbulkannya. Hingga saat ini, belum tersedia antiviral yang spesifik terhadap DENV sehingga perlu dilakukan penelitian untuk mendapatkan antiviral yang spesifik untuk DENV. Penelitian ini bertujuan menguji efek ekstrak daun Cynometra ramiflora Linn. in vitro pada sel Huh7it-1 untuk menilai potensi tanaman tersebut sebagai terapi spesifik untuk menanggulangi infeksi DENV. Dilakukan pengenceran terhadap ekstrak C. ramiflora Linn. dengan konsentrasi 40 μg/ml, 20 μg/ml, 10 μg/ml, 5 μg/ml, 2,5 μg/ml, dan 1,25 μg/ml. Selanjutnya, DENV dipaparkan dengan variasi konsentrasi ekstrak tersebut. Penghambatan replikasi virus ditentukan dengan pengukuran titer virus menggunakan uji Focus Assay, sedangkan efek toksisitas ditentukan dengan menggunakan metode MTT Assay. Dari kedua uji tersebut didapatkan nilai CC50 dan IC50 masing-masing sebesar 125 μg/ml dan 20,1 μg/ml sehingga didapatkan indeks selektivitas sebesar 6,2. Dapat disimpulkan bahwa ekstrak C. ramiflora Linn. tidak toksik dan memiliki potensi antiviral.

---

Dengue virus (DENV) causes an acute infection that may lead to death. Due to the morbidity and mortality produced, dengue infection is still a serious health problem especially in tropical countries. To this time, there is still no specific antiviral to overcome DENV. Therefore, a research to find a specific antiviral for DENV is necessary. This research is aimed to evaluate the effect of Cynometra ramiflora Linn. leaf extract in vitro on Huh7it-1 cell as a specific antiviral for DENV infection. The leaf extract of C. ramiflora Linn. was diluted to concentration 40 μg/ml, 20 μg/ml, 10 μg/ml, 5 μg/ml, 2,5 μg/ml, and 1,25 μg/ml. Next, DENV was exposed to those concentration. The inhibition of DENV replication was observed using Focus Assay, while the toxicity of the extract to Huh7it-1 was evaluated using MTT Assay. From the experiment, the value of CC50 and IC50 are 125 μg/ml and 20,1 μg/ml, respectively. From the research, it can be concluded that C. ramiflora Linn. extract is not toxic and has a potency for antiviral."

" ABSTRAKInfeksi virus Dengue DENV masih menjadi masalah kesehatan global terutama didaerah tropis dan subtropis termasuk di Indonesia. Sampai saat ini belum ditemukanvaksin dan antiviral yang efektif untuk mencegah dan mengobati infeksi DENV.Ekstrak daun mengkudu Morinda citrifolia Linn diketahui memiliki efekmenghambat infeksi beberapa jenis virus dan bakteri. Penelitian ini bertujuan untukmengetahui kemampuan ekstrak daun Morinda citrifolia Linn pada konsentrasi 20 g/ml, 10 g/ml, 5 g/ml, 2,5 g/ml, dan 1,25 g/ml dalam menghambatpertumbuhan DENV2 pada sel Huh-7,5 yang diinfeksi DENV2 dengan multiplicityof infection 0,5. Fokus virus yang terbentuk divisualisasi melalui immunoassay danjumlah fokus antara kelompok perlakukan dibandingkan dengan kelompok kontrolpositif berupa sel Huh-7.5 yang terinfeksi DENV2 tanpa penambahan ekstrak daunMorinda citrifolia Linn. Secara statistik, pemberian ekstrak daun mengkudu dengankonsentrasi 1,25 ?g/ml memberikan hasil penghambatan yang signifikan p 0,05 .Kata kunci: DENV2, mengkudu Morinda citrifolia Linn , replikasi virus

---

ABSTRAKDengue viral infection remains become one of the global health burden particularlyin tropical and subtropical area include in Indonesia. Till nowadays there is nospecific vaccine and antiviral to prevent and cure Dengue viral infection. Morindacitrifolia Linn leave extract has been known has the antiviral and antibacterialactivity. This research is aimed to know the effects of Morinda citrifolia Linn leavesextract in five different concentrations 20 g ml, 10 g ml, 5 g ml, 2,5 g ml, and1,25 g ml in inhibiting the replication of DENV2 on Huh 7.5 cells infected byDENV2 with multiplicity of infection 0,5. Foci that formed is visualized byimmunoassay and the amount of foci in each group is compared to positif controlthat Huh 7.5 cells is infected by DENV2 without addition of Morinda citrifolia Linnleaves extract. Statistically, addition 1,25 g ml of Morinda citrifolia Linn leaveextract shows significant inhibiting result p 0,05 .Key Words DENV2, Morinda citrifolia Linn, viral replication"

"ABSTRAKInfeksi virus dengue DENV masih menjadi masalah serius baik di dunia maupun di Indonesia. Spektrum klinis dengue yang terdiri atas demam berdarah dengue DBD dan sindrom syok dengue SSD menyebabkan kematian. Terapi definitif belum tersedia saat ini, sehingga masih mengandalkan terapi suportif. Berbagai tanaman sebagai antivirus telah banyak dieksplorasi. Salah satu tanaman diketahui memiliki efek antivirus berasal genus Calophyllum. Penelitian ini bertujuan untuk menganalisis potensi inhibisi replikasi virus dengue serotipe 2 oleh fraksi air Calophyllum nodosum pada sel Huh7it. Dua metode yang digunakan antara lain MTT 3- 4, 5-dimethylthiazolyl-2 -2, 5-diphenyltetrazolium bromide assay dan focus assay. MTT assay menilai viabilitas sel pada sel yang tidak terinfeksi, sedangkan focus assay menilai titer virus yang menggambarkan hambatan infektivitas DENV. Hasil menunjukkan antara perlakuan dan kontrol pada kelompok viabilitas tidak berbeda bermakna dengan nilai half cytotoxic concentration CC50 2729 g/mL, sedangkan perbedaan bermakna ditemukan pada kelompok infektivitas dengan nilai half inhibitory concentration IC50 10,87 g/mL. Indeks Selektivitas IS yang didapatkan sebesar 251,06. Fraksi air Calophyllum nodosum berpotensi menghambat replikasi DENV-2 secara in vitro.

---

ABSTRACTInfection by Dengue virus DENV is still a serious problem around the world including in Indonesia. Clinical Dengue spectrum from bleeding dengue fever to dengue shock syndrome lead to mortality. Definitive therapy is not available so that the treatment still relies on supportive therapy. Various herbs as antiviral have been widely explored. Calophyllum genus is known to have an antiviral effect. This study aims to analyze and assess inhibition potential of dengue virus serotype 2 replication by Calophyllum nodosum water fraction in Huh7it cell. Two methods were used including MTT 3 4, 5 dimethylthiazolyl 2 2, 5 diphenyltetrazolium bromide assay and focus assay. MTT assay was to assess uninfected cell viability, whereas focus assay aims to assess virus titer which describes DENV infectivity. The results showed viability group did not has a significant difference with half cytotoxic concentration CC50 2729 g mL, whereas infectivity group was significantly different with half inhibitory concentration CC50 10,87 g mL. The selectivity index was 251,06. Calophyllum nodosum water fraction is potential to inhibit DENV 2 replication in vitro."

"[ABSTRAKKasus Demam Berdarah Dengue (DBD) dan demam dengue (DD) dilaporkan meningkat di seluruh dunia setiap tahunnya, terutama di negara Asia Tenggara termasuk Indonesia Gambaran klinis dari DBD/DD adalah demam, sakit kepala, nyeri otot dan sendi, ruam kulit yang mirip dengan campak, dan hasil lab menunjukkan penurunan jumlah trombosit. Hingga saat ini belum ada antiviral khusus untuk DBD. Penelitian ini bertujuan untuk mengevaluasi pengaruh virgin coconut oil (VCO) terhadap replikasi virus dengue (DENV). Penelitian ini merupakan penelitian eksperimental yang dilakukan di Laboratorium Mikrobiologi, Departemen Mikrobiologi, Fakultas Kedokteran Universitas Indonesia. Data yang diperoleh ini berasal dari hasil eksperimen yang dilakukan dengan 6 pengulangan untuk setiap perlakuan yaitu pemberian VCO 5%, 1%, 0,5% dan 0,1%, kontrol negatif dan Dimethyl Sulfoxide (DMSO).Penghambatan replikasi DENV dilihat dengan menghitung titer virus setelah perlakuan VCO. Titer virus dihitung dengan menggunakan metode focus assay. Hasil penelitian menunjukkan bahwa IC50 dari VCO adalah kuat, sementara CC50 VCO adalah moderat. Hal ini menunjukkan bahwa secara signifikan VCO menghambat replikasi DENV dengan kisaran cukup aman untuk digunakan pada sel dalam dosis terbatas. Penelitian lebih lanjut perlu dilakukan untuk mengevaluasi efek VCO pada replikasi DENV in vivo, sehingga dapat ditemukan kandidat anti DENV di masa mendatang.

---

ABSTRACTCases of the Dengue Hemorrhagic Fever (DHF)/Dengue Fever (DF) were reported increasing worldwide annually, especially in South Asia counties including Indonesia The clinical features of DF/DHF are fever, headache, muscle and joint pains, a characteristic skin rash that is similar to measles, which lead to thrombocytopenia as a lab result. Until now, specific antiviral for dengue virus (DENV) is not available yet.The objective of this research was to evaluate the effect of virgin coconut oil (VCO) to the DENV replication. This research was experimental study and was conducted at Microbiology laboratory, Department of Microbiology, Faculty of Medicine University of Indonesia. The data that was obtained for this study came from the experimental studied with 6 repeated experiments for each treatment of various concentartion of 5%, 1%, 0.5% and 0.1% as well as negative control and Dimethyl Sulfoxide (DMSO). Inhibition of DENV replication was determined by calculating of DENV titer after treated with VCO. The focus assay was used to calculate the DENV titer. The result showed that IC50 and CC50 of VCO was strong and moderate respectively. VCO was significantly inhibited the replication of DENV with adequate safe range to use for cells within limited dosages. Therefore, we concluded that VCO can be a candidate antiviral for DENV. Next study is needed to evaluate the effect of VCO in vivo, therefore we will find an antiviral of DENV virus in future.;Cases of the Dengue Hemorrhagic Fever (DHF)/Dengue Fever (DF) were reported increasing worldwide annually, especially in South Asia counties including Indonesia The clinical features of DF/DHF are fever, headache, muscle and joint pains, a characteristic skin rash that is similar to measles, which lead to thrombocytopenia as a lab result. Until now, specific antiviral for dengue virus (DENV) is not available yet.The objective of this research was to evaluate the effect of virgin coconut oil (VCO) to the DENV replication. This research was experimental study and was conducted at Microbiology laboratory, Department of Microbiology, Faculty of Medicine University of Indonesia. The data that was obtained for this study came from the experimental studied with 6 repeated experiments for each treatment of various concentartion of 5%, 1%, 0.5% and 0.1% as well as negative control and Dimethyl Sulfoxide (DMSO).Inhibition of DENV replication was determined by calculating of DENV titer after treated with VCO. The focus assay was used to calculate the DENV titer. The result showed that IC50 and CC50 of VCO was strong and moderate respectively. VCO was significantly inhibited the replication of DENV with adequate safe range to use for cells within limited dosages. Therefore, we concluded that VCO can be a candidate antiviral for DENV. Next study is needed to evaluate the effect of VCO in vivo, therefore we will find an antiviral of DENV virus in future., Cases of the Dengue Hemorrhagic Fever (DHF)/Dengue Fever (DF) were reported increasing worldwide annually, especially in South Asia counties including Indonesia The clinical features of DF/DHF are fever, headache, muscle and joint pains, a characteristic skin rash that is similar to measles, which lead to thrombocytopenia as a lab result. Until now, specific antiviral for dengue virus (DENV) is not available yet.The objective of this research was to evaluate the effect of virgin coconut oil (VCO) to the DENV replication. This research was experimental study and was conducted at Microbiology laboratory, Department of Microbiology, Faculty of Medicine University of Indonesia. The data that was obtained for this study came from the experimental studied with 6 repeated experiments for each treatment of various concentartion of 5%, 1%, 0.5% and 0.1% as well as negative control and Dimethyl Sulfoxide (DMSO).Inhibition of DENV replication was determined by calculating of DENV titer after treated with VCO. The focus assay was used to calculate the DENV titer. The result showed that IC50 and CC50 of VCO was strong and moderate respectively. VCO was significantly inhibited the replication of DENV with adequate safe range to use for cells within limited dosages. Therefore, we concluded that VCO can be a candidate antiviral for DENV. Next study is needed to evaluate the effect of VCO in vivo, therefore we will find an antiviral of DENV virus in future.]"

"Infeksi dengue masih merupakan masalah kesehatan di Indonesia sebagai negara endemik. Sampai saat ini, belum ditemukan terapi definitif sebagai tatalaksana infeksi dengue. Penelitian untuk pengembangan antivirus dengue sudah banyak dilakukan. Ekstrak Calophyllum canum, sebagai salah satu tanaman yang tumbuh di Kalimantan, ditemukan memiliki efek anti mikroganisme. Penelitian dilakukan untuk menguji efek antiviral dari crude extract batang C. canum fraksti etil asetat terhadap replikasi virus dengue serotipe-2 (DENV-2) pada sel Huh7it-1 dengan focus assay dan MTT assay untuk menguji sitotoksitas pada sel tidak terinfeksi. Nilai IC50 dari ekstrak C. canum pada sel Huh7it-1 adalah 123,96 μg/mL dan nilai CC50 adalah 620,57 μg/mL. Indeks selektivitas adalah 5,01. Pada focus assay terdapat perbedaan bermakna antara tiap perlakuan dengan kontrol (p<0,001) namun pada MTT assay tidak terdapat perbedaan bermakna antara tiap perlakuan dengan kontrol (p≥0,05). Crude extract dari batang C. canum memiliki efek inhibisi terhadap replikasi DENV-2 secara in Vitro pada sel Huh7it-1.

---

Until now, dengue infection is still a health concern in Indonesia. There is no definite treatment for dengue infection. The development of dengue antivirus using natural extract of plant have been conducted. Calophyllum canum, a plant that grow in Kalimantan was discovered to have anti-microorganism effect. In present study, crude extract of C. canum stem in ethyl acetate fraction was used to examine the antiviral effect on dengue virus seroptype-2 (DENV-2) replication on Huh7it-1. The inhibition of DENV-2 replication was determined by focus assay. The cytotoxicity of uninfected cells by MTT assay. The IC50 value of C. canum on Huh7it-1 cells was 123.96 μg/mL and the CC50 value was 620.57 μg/mL. The selectivity index was 5.01. There was significant difference on focus assay between all concentration with control (p<0.001), but there was no significant difference in MTT assay (p≥0.05). Crude extract of C. canum stem showed inhibition effect on DENV-2 replication in vitro on Huh7it-1 cells."

"[Infeksi dengue merupakan penyakit akibat DENV yang terdiri atas 4 serotipe,yaitu serotipe 1, 2, 3, dan 4. Penyakit dengue dapat ditemukan pada lebih dari 100negara di dunia. Indonesia adalah negara dengan kasus DBD tertinggi di AsiaTenggara, dengan angka penderita yang terus meningkat sejak tahun 1968 (58kasus) sampai 2009 (158.912 kasus). Sampai saat ini, tata laksana yang dilakukanadalah terapi suportif berupa pemberian cairan yang diobservasi dengan ketat.Antivirus terhadap DENV belum ditemukan, meskipun sebagian negaramenggunakan obat-obat tradisional dalam menangani infeksi DENV. Padapenelitian ini dilakukan evaluasi efek antiviral ekstrak daun Cinnamomumburmannii sebagai antivirus DENV dengan menggunakan sel Huh7it-1. Ujihambatan infektivitas dilakukan dengan focus assay sehingga didapatkan nilaiIC50 sedangkan uji sitotoksisitas dilakukan dengan MTT assay sehinggadidapatkan nilai CC50-nya. Indeks selektivitas (SI) didapatkan melalui pembagianCC50 dengan IC50 dan merupakan gambaran potensi ekstrak sebagai antivirus.Pada penelitian ini, ditemukan bahwa ekstrak daun C. burmannii dapatmenghambat replikasi DENV-2 dengan IC50 96,07 μg/ml; CC50 346,45 μg/ml; danSI 3,60. Dapat disimpulkan bahwa ekstrak daun Cinnamomum burmannii kurangpoten sebagai antivirus DENV., Dengue infection is a disease caused by four serotypes of DENV: serotype 1, 2, 3,and 4. Disease caused by DENV can be found in more than 100 countries in theworld. Indonesia is the country with the highest number of DHF cases in South-East Asia, with an increasing number of sufferers from 1968 (58 cases) to 2009(158.912 cases). To this day, supportive therapy by fluid replacement is used totreat DENV infection. No antivirus has been found, even though many countrieshave used traditional medicine to treat dengue infection. In this research,Cinnamomum burmannii, a plant commonly found in Indonesia, is evaluated forits antiviral potency towards DENV using Huh7it-1 cells. Inhibition of DENVinfectivity is measured through focus assay to acquire IC50, while citotoxicity ismeasured by MTT assay to acquire its CC50. Selectivity index (SI) can be foundthrough calculation of CC50 divided by IC50. From this research, it has been foundthat C. burmannii leaf extract is capable of inhibiting DENV-2 replication with96.07 μg/ml IC50; 346.45 μg/ml CC50; and 3.60 SI score. In conclusion, the leafextract of C. burmannii is not very potent as an antivirus towards DENV]"